Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | — | 8M |
| Research and development | 38,000 | 7M |
| Selling, general and administrative | 5M | 8M |
| Operating expenses | 5M | 18M |
| Operating income | −5M | −10M |
| Net income | −5M | −10M |
| Earnings per share | −1.41 | −2.62 |
| Earnings per share, diluted | −1.41 | −2.62 |
| Weighted average shares | 4M | 4M |
| Weighted average shares, diluted | 4M | 4M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3M | 4M | 5M | 6M | 8M | 10M | 11M | 12M |
| Receivables | — | — |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | −5M | −11M |
| Depreciation and amortisation | — | 106,000 |
| Share-based compensation | 25,000 | 511,000 |
| Capital expenditure | — | 398,000 |
| Investing cash flow | — | −398,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| — |
| — |
| 16,000 |
| — |
| 23,000 |
| 635,000 |
| Current assets | 4M | 4M | 5M | 6M | 8M | 10M | 11M | 16M |
| Total assets | 4M | 4M | 5M | 6M | 8M | 10M | 12M | 16M |
| Current liabilities | 905,000 | 329,000 | 249,000 | 548,000 | 903,000 | 929,000 | 590,000 | 2M |
| Total liabilities | 905,000 | 329,000 | 249,000 | 548,000 | 904,000 | 996,000 | 590,000 | 2M |
| Equity | 4M | 4M | 5M | 6M | 7M | 9M | 11M | 13M |
| Shares outstanding | 4M | 4M | 4M | 4M | 4M | 4M | 4M | 4M |
| Shares issued | 4M | 4M | 4M | 4M | 4M | 4M | 4M | 4M |